Drug

Cemiplimab-rwlc

41 flagged reaction(s) · 755 total co-reports · max PRR 45.4

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Myocarditis	49	45.4	46.5	signal
2	Adrenal Insufficiency	24	21.0	21.2	signal
3	Hepatic Cytolysis	23	19.7	19.9	signal
4	Squamous Cell Carcinoma	16	17.8	17.9	signal
5	Cholestasis	26	14.2	14.4	signal
6	Pneumonitis	35	13.5	13.8	signal
7	Disease Progression	152	13.5	14.5	signal
8	Hypothyroidism	36	11.8	12.0	signal
9	Metastases To Lung	12	10.9	10.9	signal
10	Hyperthyroidism	15	10.8	10.9	signal
11	Interstitial Lung Disease	46	10.0	10.2	signal
12	Basal Cell Carcinoma	13	8.7	8.7	signal
13	Hypercalcaemia	10	8.5	8.5	signal
14	Colitis	30	8.3	8.4	signal
15	Ischaemic Stroke	14	8.2	8.2	signal
16	Hepatitis	20	8.2	8.2	signal
17	Neoplasm	9	8.2	8.2	signal
18	Toxic Epidermal Necrolysis	11	7.6	7.7	signal
19	Hepatocellular Injury	10	7.3	7.4	signal
20	Polyneuropathy	8	7.0	7.1	signal
21	Rash Maculo-papular	14	6.6	6.6	signal
22	Hepatotoxicity	14	6.6	6.6	signal
23	Skin Lesion	17	6.5	6.6	signal
24	Metastases To Central Nervous System	7	5.7	5.7	signal
25	Transaminases Increased	12	5.6	5.7	signal
26	Autoimmune Disorder	5	5.5	5.5	signal
27	Pharyngeal Oedema	8	5.4	5.4	signal
28	Hospice Care	5	5.3	5.3	signal
29	Stevens-johnson Syndrome	11	5.2	5.2	signal
30	Eyelid Ptosis	5	5.1	5.1	signal
31	Infusion Related Reaction	31	4.9	5.0	signal
32	Therapy Partial Responder	7	4.9	4.9	signal
33	Wound Infection	5	4.8	4.8	signal
34	Neoplasm Progression	16	4.8	4.8	signal
35	Blood Thyroid Stimulating Hormone Increased	4	4.5	4.5	signal
36	Skin Reaction	6	4.5	4.5	signal
37	Pemphigus	5	4.2	4.2	signal
38	Diabetic Ketoacidosis	9	3.9	3.9	signal
39	Eosinophilia	6	3.6	3.6	signal
40	Cytokine Release Syndrome	6	3.3	3.3	signal
41	Uveitis	3	2.3	2.3	no signal